Shenzhen Weiguang Biological Products Co.Ltd(002880) (SZ Shenzhen Weiguang Biological Products Co.Ltd(002880) , closing price: 31.46 yuan) announced on March 8 that the matters related to the non-public offering of shares have been deliberated and approved at the second meeting of the third board of directors of the company, and the approval of the state owned assets supervision and Administration Bureau of Guangming district on Shenzhen Weiguang Biological Products Co.Ltd(002880) the non-public offering of shares has been obtained. The objects of this non-public offering are no more than 35 specific objects that meet the conditions stipulated by the CSRC. The number of shares in this non-public offering does not exceed 34.34 million (including this number), which does not exceed 30% of the total share capital of about 227 million shares before this non-public offering, and shall be subject to the approval document of the CSRC on this offering. The issuing price of the shares shall not be lower than 80% of the average trading price of the 20 trading days before the pricing benchmark date. This offering is intended to raise no more than RMB 1.15 billion. The construction project of blood products intelligent factory has a total investment of about 910 million yuan, and 768 million yuan is planned to be invested; Zhongshan plasma collection station project has a total investment of 869148 million yuan and plans to invest 43 million yuan to raise funds; The project of replenishing working capital has a total investment of 339 million yuan and plans to invest 339 million yuan of raised funds.
Shenzhen Weiguang Biological Products Co.Ltd(002880) ‘s chairman is Zhang Zhan, male, 50 years old, with a master’s degree background; The general manager is Guo Caiping, female, 51 years old, with a doctorate background.
